DAFNA Capital Management as of Dec. 31, 2013
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 47 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Discovery Laboratories Com New | 13.2 | $13M | 5.7M | 2.25 | |
| Pharmacyclics | 11.8 | $12M | 109k | 105.78 | |
| AtriCure (ATRC) | 8.8 | $8.5M | 457k | 18.68 | |
| Stereotaxis Com New (STXS) | 6.5 | $6.3M | 1.7M | 3.62 | |
| Given Imaging Ord Shs | 4.8 | $4.7M | 156k | 30.08 | |
| Novadaq Technologies | 4.8 | $4.7M | 284k | 16.49 | |
| Protalix BioTherapeutics | 4.7 | $4.6M | 1.2M | 3.89 | |
| Insulet Corporation (PODD) | 4.6 | $4.5M | 122k | 37.10 | |
| Insulet Corp Note 3.750% 6/1 (Principal) | 4.5 | $4.4M | 3.0M | 1.46 | |
| NxStage Medical | 4.0 | $3.8M | 384k | 10.00 | |
| Ampio Pharmaceuticals | 3.1 | $3.0M | 426k | 7.13 | |
| Merrimack Pharmaceuticals In | 1.9 | $1.8M | 343k | 5.33 | |
| Biotelemetry | 1.8 | $1.7M | 216k | 7.94 | |
| Biota Pharmaceuticals | 1.4 | $1.4M | 327k | 4.19 | |
| Threshold Pharmaceutical Com New | 1.3 | $1.3M | 281k | 4.67 | |
| Spectranetics Corporation | 1.3 | $1.3M | 52k | 25.00 | |
| Venaxis | 1.3 | $1.3M | 590k | 2.14 | |
| BioSpecifics Technologies | 1.2 | $1.1M | 52k | 21.67 | |
| Syneron Medical Ord Shs | 1.2 | $1.1M | 91k | 12.30 | |
| Nuvasive Note 2.750% 7/0 (Principal) | 1.1 | $1.1M | 1.0M | 1.09 | |
| Cardica | 1.1 | $1.0M | 1.1M | 0.98 | |
| XenoPort | 1.0 | $1.0M | 177k | 5.75 | |
| OncoGenex Pharmaceuticals | 1.0 | $928k | 111k | 8.34 | |
| Cutera (CUTR) | 0.9 | $903k | 89k | 10.18 | |
| Conatus Pharmaceuticals | 0.9 | $875k | 136k | 6.45 | |
| Johnson & Johnson (JNJ) | 0.9 | $861k | 9.4k | 91.60 | |
| Ocera Therapeutics | 0.8 | $821k | 63k | 12.99 | |
| Adamis Pharmaceuticals Corp Com New | 0.8 | $799k | 125k | 6.39 | |
| Uroplasty Com New | 0.8 | $790k | 289k | 2.73 | |
| Clovis Oncology | 0.8 | $759k | 13k | 60.24 | |
| Exactech | 0.8 | $752k | 32k | 23.77 | |
| Inspiremd Com New | 0.7 | $705k | 287k | 2.46 | |
| Intercept Pharmaceuticals In | 0.7 | $655k | 9.6k | 68.24 | |
| Derma Sciences Com Par $.01 | 0.6 | $617k | 57k | 10.82 | |
| RTI Biologics | 0.6 | $591k | 167k | 3.54 | |
| Keryx Biopharmaceuticals | 0.6 | $570k | 44k | 12.95 | |
| Dyax | 0.6 | $569k | 76k | 7.54 | |
| Dynavax Technologies Corporation | 0.6 | $568k | 290k | 1.96 | |
| Masimo Corporation (MASI) | 0.5 | $512k | 18k | 29.26 | |
| Curis | 0.4 | $423k | 150k | 2.82 | |
| Baxano Surgical I | 0.3 | $340k | 336k | 1.01 | |
| Tg Therapeutics (TGTX) | 0.3 | $293k | 75k | 3.91 | |
| Synthetic Biologics | 0.3 | $283k | 185k | 1.53 | |
| Palatin Technologies Com Par $.01 | 0.3 | $253k | 345k | 0.73 | |
| Chembio Diagnostics | 0.2 | $186k | 55k | 3.37 | |
| Retractable Technologies (RVP) | 0.1 | $62k | 20k | 3.10 | |
| Combimatrix Corp *w Exp 05/01/201 | 0.0 | $999.982500 | 2.3k | 0.43 |
